NYSEMKT: CPHIChina Pharma Holdings Revenue
China Pharma Holdings revenue was $4.40M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $1.0M, down 9.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CPHI annual revenue was $4.5M, with -35.4% growth year-over-year.
CPHI past revenue growth
How has CPHI's revenue growth performed historically?
Company
-29.64%
Industry
6.84%
Market
20.08%
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CPHI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CPHI revenue history
Current Revenue
$4.4M
Current Earnings
-$3.7M
Current Profit Margin
-83.2%
Be the first to know when CPHI announces revenue.
CPHI Revenue History By Year
| CPHI Yearly Revenue | CPHI Revenue | CPHI Change | CPHI Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $4.53M | -$2.48M | -35.41% |
| 2023-12-31 | $7.01M | -$1.09M | -13.48% |
| 2022-12-31 | $8.10M | -$1.54M | -15.95% |
| 2021-12-31 | $9.64M | -$1.22M | -11.27% |
| 2020-12-31 | $10.87M | -$57.49k | -0.53% |
| 2019-12-31 | $10.92M | -$1.41M | -11.41% |
| 2018-12-31 | $12.33M | -$881.63k | -6.67% |
| 2017-12-31 | $13.21M | -$2.36M | -15.15% |
| 2016-12-31 | $15.57M | -$4.78M | -23.49% |
| 2015-12-31 | $20.35M | -$1.78M | -8.05% |
| 2014-12-31 | $22.13M | -$10.67M | -32.53% |
| 2013-12-31 | $32.81M | -$21.70M | -39.81% |
| 2012-12-31 | $54.51M | -$26.66M | -32.85% |
| 2011-12-31 | $81.17M | $6.78M | +9.11% |
| 2010-12-31 | $74.39M | $12.69M | +20.57% |
| 2009-12-31 | $61.70M | $10.73M | +21.05% |
| 2008-12-31 | $50.97M | $17.78M | +53.58% |
| 2007-12-31 | $33.19M | N/A | N/A |
China Pharma Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.